While our findings do not establish causation, they highlight the need for further observational studies, post-marketing surveillance, and mechanistic research to clarify the relationship between GLP-1 RAs and pancreatic mucinous cystic neoplasms, in addition to their effect on preexisting cysts
They are not associated with cardiovascular protection beyond glucose lowering, so they are typically chosen when GLP-1 agonists or SGLT2 inhibitors are unsuitable
Patel, H., Khunti, K., Rodbard, H
Drug-induced depression may be difficult to pinpoint, but a healthcare provider can help determine if medication is contributing to mood changes
However, not everyone notices immediate changes
This research demonstrates that GLP-1 safety extends beyond controlled clinical trials to everyday medical practice